News
(HealthDay News) — From 2010 to 2014 there was an increase in use of diabetes medications, including sulfonylureas and dipeptidyl peptidase-4 inhibitors (DPP-4 inhibitors), among patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback